Displaying drugs 4751 - 4775 of 5926 in total
3-(N-morpholino)propanesulfonic acid
Experimental
3-(3,4-dimethoxyphenyl)propanoic acid
Experimental
SALOPHEN-10-PROPIONATE IRON CHELATE
Experimental
1,3-Bis((1-methylethyl)amino)propan-2-ol
Experimental
Lonigutamab
Lonigutamab is under investigation in clinical trial NCT05683496 (Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)).
Investigational
KAI-1455
KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and hip replacement and may protect against renal injury associated with contrast media. Several studies...
Investigational
Matched Description: … KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury …
2-deoxy-2-fluoro-β-D-mannose
Experimental
Phthalocyanine
Phthalocyanine is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides).
Investigational
N-Acetylmethionine
Experimental
Zanidatamab
According to Zymeworks, "ZW25 is a bispecific antibody that can simultaneously bind two non-overlapping epitopes, known as biparatopic binding, of HER2 resulting in dual HER2 signal blockade, increased binding and removal of HER2 protein from the cell surface, and potent effector function. These combined mechanisms of action have led to...
Investigational
Matched Description: … biparatopic binding, of HER2 resulting in dual HER2 signal blockade, increased binding and removal of HER2 protein …
2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole
Experimental
5-Hydroxy-N-Propargyl-1(R)-Aminoindan
Experimental
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN
Experimental
Farnesyl thiopyrophosphate
Experimental
G17DT Immunogen
G17DT Immunogen is a vaccine that neutralizes gastrin-17, a hormone required for the growth of a number of cancers of the gastrointestinal tract. It is in phase III trials for advanced pancreatic cancer as a monotherapy and in combination with gemcitabine. It is also in a phase II/III trial for...
Investigational
Cosfroviximab
Investigational
Fosgemcitabine palabenamide
NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).
Investigational
Vitex agnus-castus fruit extract
Vitex agnus-castus fruit extract is obtained from dry fruits of Vitex agnus-castus. The fruits contain mixture of iridoids, flavonoids and compounds in leaves and flowers that structurally resemble sex hormones. Clinical studies demonstrates effectiveness of vitex agnus-castus fruit extract in the management of premenstrual stress syndrome (PMS) and cyclical breast...
Experimental
BMS-833923
Investigational
trans-2-hydroxycinnamic acid
Experimental
Baxdrostat
Baxdrostat is under investigation in clinical trial NCT06344104 (A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Asian Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension).
Investigational
BLU-9931
Investigational
AQ-13
AQ-13 is an 4-aminoquinoline analog being investigated for the treatment of malaria.
Investigational
Coagulation factor XIa
Coagulation factor XIa is under investigation in clinical trial NCT01701947 (HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency).
Investigational
Ladostigil
Ladostigil is under investigation in clinical trial NCT01429623 (A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment).
Investigational
Displaying drugs 4751 - 4775 of 5926 in total